MX2021009957A - Dispositivos de administracion de farmacos compartimentados. - Google Patents

Dispositivos de administracion de farmacos compartimentados.

Info

Publication number
MX2021009957A
MX2021009957A MX2021009957A MX2021009957A MX2021009957A MX 2021009957 A MX2021009957 A MX 2021009957A MX 2021009957 A MX2021009957 A MX 2021009957A MX 2021009957 A MX2021009957 A MX 2021009957A MX 2021009957 A MX2021009957 A MX 2021009957A
Authority
MX
Mexico
Prior art keywords
compartmentalized
drug delivery
delivery devices
outer shape
active pharmaceutical
Prior art date
Application number
MX2021009957A
Other languages
English (en)
Inventor
Jason L Mcconnell
Mark A Mitchnick
Bruce L Frank
Onajite Okoh
Original Assignee
Particle Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Particle Sciences Inc filed Critical Particle Sciences Inc
Publication of MX2021009957A publication Critical patent/MX2021009957A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Laminated Bodies (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Se proporciona un dispositivo de administración de agentes farmacéuticos activos que se compone de una forma exterior polimérica hueca que forma al menos una cavidad o compartimento interno cerrado y que contiene un núcleo sólido de uno o más agentes farmacéuticos activos y uno o más excipientes sustancialmente desvinculados de la forma exterior polimérica hueca. También se proporcionan métodos para la producción y uso de este dispositivo.
MX2021009957A 2019-02-19 2020-02-14 Dispositivos de administracion de farmacos compartimentados. MX2021009957A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962807336P 2019-02-19 2019-02-19
PCT/US2020/018326 WO2020172065A1 (en) 2019-02-19 2020-02-14 Compartmentalized drug delivery devices

Publications (1)

Publication Number Publication Date
MX2021009957A true MX2021009957A (es) 2021-11-12

Family

ID=70005715

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021009957A MX2021009957A (es) 2019-02-19 2020-02-14 Dispositivos de administracion de farmacos compartimentados.

Country Status (13)

Country Link
US (1) US20220125715A1 (es)
EP (1) EP3927316A1 (es)
JP (1) JP2022520667A (es)
KR (1) KR20210129090A (es)
CN (1) CN113677326A (es)
AU (1) AU2020226355A1 (es)
BR (1) BR112021016369A2 (es)
CA (1) CA3130212A1 (es)
CR (1) CR20210475A (es)
IL (1) IL285673A (es)
MX (1) MX2021009957A (es)
SG (1) SG11202108932QA (es)
WO (1) WO2020172065A1 (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4402695A (en) * 1980-01-21 1983-09-06 Alza Corporation Device for delivering agent in vagina
US20090208540A1 (en) * 2003-08-11 2009-08-20 Indevus Pharmaceuticals, Inc. Implantable device for the delivery of naltrexone and methods of use thereof
CA2437639C (en) 2003-08-11 2016-07-05 Valera Pharmaceuticals, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
CN103796708A (zh) * 2011-07-20 2014-05-14 帕特里克.F.凯瑟 用于递送药物的阴道内装置
CN107582514A (zh) * 2011-10-24 2018-01-16 布雷本制药有限公司 可植入的药物递送组合物及其治疗方法
AR089765A1 (es) * 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
AU2014215459A1 (en) * 2013-02-05 2015-09-17 The Population Council, Inc. Intravaginal ring for the delivery of unique combinations of antimicrobial compositions
WO2018202574A1 (en) * 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception

Also Published As

Publication number Publication date
CA3130212A1 (en) 2020-08-27
BR112021016369A2 (pt) 2021-10-19
AU2020226355A1 (en) 2021-09-02
EP3927316A1 (en) 2021-12-29
CN113677326A (zh) 2021-11-19
IL285673A (en) 2021-10-31
CR20210475A (es) 2021-10-18
US20220125715A1 (en) 2022-04-28
SG11202108932QA (en) 2021-09-29
KR20210129090A (ko) 2021-10-27
JP2022520667A (ja) 2022-03-31
WO2020172065A1 (en) 2020-08-27

Similar Documents

Publication Publication Date Title
CO2019008487A2 (es) Compuesto de quinazolina
EP4331677A3 (en) Methods of treating feline coronavirus infections
PH12019500579A1 (en) Pharmaceutical composition
NZ631100A (en) Soft chewable pharmaceutical products
NZ727975A (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
PH12015502628B1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
ECSP055528A (es) Composicion farmaceutica que tiene una distribución y potencia uniforme de farmaco
MX2021004546A (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
CO6450625A2 (es) Sistema intrauterino para uso en tratamiento médico
MX2018004328A (es) Composiciones farmaceuticas estabilizantes de camptotecina.
BR112015023481A2 (pt) composição de lipossoma de liberação controlada de fármaco
EA201501164A1 (ru) Твердая фармацевтическая лекарственная форма
MY191875A (en) Solid dosage form
WO2016130800A3 (en) Pharmaceutical compositions comprising perillyl alcohol derivatives
BR112022000982A2 (pt) Forma de dosagem veterinária mastigável macia
AR084696A1 (es) Tapones lagrimales con mecanismo de liberacion de farmacos continuo o pulsatil
MX2019008870A (es) Agente terapeutico para enfermedades hepaticas.
CR20210475A (es) Dispositivos de administración de fármacos compartimentados
MX2020001399A (es) Agentes antifungicos con actividad mejorada en ph acido.
MX2021001349A (es) Un nuevo tratamiento medico para la inflamacion patologica.
PE20130659A1 (es) Dispositivos intravaginales que comprenden agentes anticolinergicos y metodos para prepararlos
AR086279A1 (es) Tapones lagrimales para la liberacion controlada de agentes terapeuticos
PH12016502540A1 (en) Pharmaceutical dosage forms
RU2013111100A (ru) Способ лечения буллезной кератопатии
TH164080B (th) รูปเเบบยาของเเข็ง